1. Fahr KT. Idiopathische verkalkung der hirngefasse. Zentralbl Allg Pathol. 1930; 50:129–33.
2. Manyam BV. What is and what is not ‘Fahr’s disease’. Parkinsonism Relat Disord. 2005; 11:73–80.
Article
3. Wszolek ZK, Baba Y, Mackenzie IR, Uitti RJ, Strongosky AJ, Broderick DF, et al. Autosomal dominant dystoniaplus with cerebral calcifications. Neurology. 2006; 67:620–5.
Article
4. Swami A, Kar G. Intracranial hemorrhage revealing pseudohypoparathyroidism as a cause of fahr syndrome. Case Rep Neurol Med. 2011; 2011:407567.
Article
5. Al-Jehani H, Ajlan A, Sinclair D. Fahr’s disease presenting with aneurysmal subarachnoid hemorrhage. J Clin Imaging Sci. 2012; 2:27.
Article
6. Sgulo FG, di Nuzzo G, de Notaris M, Seneca V, Catapano G. Cerebrovascular disorders and Fahr’s disease: report of two cases and literature review. J Clin Neurosci. 2018; 50:163–4.
7. Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc. 2005; 80:641–51.
Article
8. Saleem S, Aslam HM, Anwar M, Anwar S, Saleem M, Saleem A, et al. Fahr’s syndrome: literature review of current evidence. Orphanet J Rare Dis. 2013; 8:156.
Article
9. Chalkias SM, Magnaldi S, Cova MA, Longo R, Pozzi-Mucelli RS. Fahr disease: significance and predictive value of CT and MR findings. Eur Radiol. 1992; 2:570–5.
Article
10. Zafar A, Khan FS. Clinical and radiological features of intracerebral haemorrhage in hypertensive patients. J Pak Med Assoc. 2008; 58:356–8.